Topical calcineurin inhibitors in cutaneous lupus erythematosus

Archives of Dermatological Research

Volumn 301, Issue 1, 2009, Pages 93-98

  Sárdy, Miklós ^a   Ruzicka, Thomas ^a   Kuhn, Annegret ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cutaneous lupus erythematosus; Pimecrolimus; Tacrolimus; Therapy; Topical calcineurin inhibitor

Indexed keywords

ANTIMALARIAL AGENT; CALCINEURIN INHIBITOR; CLOBETASOL PROPIONATE; CORTICOSTEROID DERIVATIVE; GLUCOCORTICOID; PIMECROLIMUS; SUNSCREEN; TACROLIMUS; THALIDOMIDE; TRANSCRIPTION FACTOR NFAT;

ACRODERMATITIS; APPLICATION SITE ERYTHEMA; ATOPIC DERMATITIS; BASOPHIL; BURN; CLINICAL TRIAL; DERMATITIS; DISCOID LUPUS ERYTHEMATOSUS; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ERUPTION; DRUG PROTEIN BINDING; DRUG TOLERABILITY; EOSINOPHIL; GRANULOMATOSIS; HAILEY HAILEY DISEASE; HUMAN; IMMUNOMODULATION; LANGERHANS CELL; LEG ULCER; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; LYMPHOCYTIC INFILTRATION; MONOTHERAPY; MUCOUS MEMBRANE PEMPHIGOID; PAIN; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PYODERMA GANGRENOSUM; REVIEW; ROSACEA; SKIN ATROPHY; SKIN LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TELANGIECTASIA; VITILIGO;

ADMINISTRATION, TOPICAL; ANIMALS; CALCINEURIN; CLINICAL PROTOCOLS; HUMANS; IMMUNOLOGIC FACTORS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LYMPHOCYTE ACTIVATION; NFATC TRANSCRIPTION FACTORS; SKIN; T-LYMPHOCYTES; TACROLIMUS BINDING PROTEIN 1A; TREATMENT OUTCOME;

EID: 58149165185     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-008-0894-6     Document Type: Review

References (38)

1. D Bacman A Tanbajewa M Megahed T Ruzicka A Kuhn 2003 Topical treatment with tacrolimus in lupus erythematosus tumidus Hautarzt 54 977 979 10.1007/s00105-003-0593-3
2. M Böhm M Gaubitz TA Luger D Metze G Bonsmann 2003 Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. A report of three cases Dermatology 207 381 385 10.1159/000074119
3. D Breneman AB Fleischer Jr W Abramovits J Zeichner MH Gold RS Kirsner Tacrolimus Ointment Study Group 2008 Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle J Am Acad Dermatol 58 990 999 10.1016/j.jaad.2008.02.008
4. D de la Rosa Carrillo OB Christensen 2004 Treatment of chronic discoid lupus erythematosus with topical tacrolimus Acta Derm Venereol 84 233 234 10.1080/00015550310007698
5. de Prost Y (2004) Clinical experience in children. In: Ruzicka T, Reitamo S (eds) Tacrolimus ointment. A topical immunomodulator for atopic dermatitis. Springer, Heidelberg, pp 161-183
6. ZD Draelos 2008 Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas Curr Med Res Opin 24 985 994 10.1185/030079908X280419
7. A Drüke T Gambichler P Altmeyer M Freitag A Kreuter 2004 0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosus J Dermatolog Treat 15 63 64 10.1080/09546630310017852
8. JN Gilliam RD Sontheimer 1981 Distinctive cutaneous subsets in the spectrum of lupus erythematosus J Am Acad Dermatol 4 471 475
9. Goto T, Nakagawa H (2004) Development of tacrolimus ointment. In: Ruzicka T, Reitamo S (eds) Tacrolimus ointment. A topical immunomodulator for atopic dermatitis. Springer, Heidelberg, pp 81-98
10. AK Gupta M Chow 2003 Pimecrolimus: a review J Eur Acad Dermatol Venereol 17 493 503 10.1046/j.1468-3083.2003.00692.x
11. MP Heffernan MM Nelson DI Smith JH Chung 2005 0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus Arch Dermatol 141 1170 1171 10.1001/archderm.141.9.1170
12. S Ho N Clipstone L Timmermann J Northrop I Graef D Fiorentino 1996 The mechanism of action of cyclosporin A and FK506 Clin Immunol Immunopathol 80 3 Pt 2 S40 S45 10.1006/clin.1996.0140
13. T Kanekura N Yoshii K Terasaki H Miyoshi T Kanzaki 2003 Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus Br J Dermatol 148 353 356 10.1046/j.1365-2133.2003.05186.x
14. A Kreuter T Gambichler F Breuckmann FM Pawlak M Stücker A Bader 2004 Pimecrolimus 1% cream for cutaneous lupus erythematosus J Am Acad Dermatol 51 407 410 10.1016/j.jaad.2004.01.044
15. A Kuhn S Beissert 2005 Photosensitivity in lupus erythematosus Autoimmunity 38 519 529 10.1080/08916930500285626
16. Kuhn A, Ruzicka T (2005) Classification of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Heidelberg, pp 53-57
17. Kuhn A, Sontheimer R, Ruzicka T (2005) Clinical manifestations of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Heidelberg, pp 59-92
18. A Kuhn M Sticherling G Bonsmann 2007 Clinical manifestations of cutaneous lupus erythematosus J Dtsch Dermatol Ges 5 1124 1137 10.1111/j.1610-0387.2007. 06554.x
19. CE Lampropoulos S Sangle P Harrison GR Hughes DP D'Cruz 2004 Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative Rheumatology (Oxford) 43 1383 1385 10.1093/rheumatology/ keh325
20. Lee LA (2007) Lupus erythematosus. In: Bolognia JL, Jorizzo JL, Rapini RP (eds) Dermatology, 2nd edn. Elsevier Ltd, Oxford, pp 561-569
21. Lehmann P (2005) Topical treatment of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Heidelberg, pp 337-345
22. S Meller D Bruch-Gerharz T Ruzicka B Homey 2005 Topische Behandlung des subakut-kutanen Lupus erythematodes mit Tacrolimus Hautarzt 56 368 369 10.1007/s00105-005-0921-x
23. Reitamo S (2004) Clinical experience in adults. In: Ruzicka T, Reitamo S (eds) Tacrolimus ointment. A topical immunomodulator for atopic dermatitis. Springer, Heidelberg, pp 129-160
24. J Ring A Abraham C de Cuyper K Kim T Langeland V Parra 2008 Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a >2000 patient study J Eur Acad Dermatol Venereol 22 195 203
25. J Ring M Möhrenschlager V Henkel 2008 The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy Drug Saf 31 185 198
26. M Sticherling G Bonsmann A Kuhn 2008 Diagnostic approach and treatment of cutaneous lupus erythematosus J Dtsch Dermatol Ges 6 48 59
27. M Sugano Y Shintani K Kobayashi N Sakakibara I Isomura A Morita 2006 Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus J Dermatol 33 887 891 10.1111/j.1346-8138.2006.00203.x
28. WW Ting RD Sontheimer 2001 Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations Lupus 10 171 184 10.1191/096120301667674688
29. A Tlacuilo-Parra E Guevara-Gutiérrez F Gutiérrez-Murillo A Soto-Ortiz F Barba-Gómez M Hernández-Torres 2005 Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus Rheumatology (Oxford) 44 1564 1568 10.1093/rheumatology/kei093
30. TY Tzung YS Liu HW Chang 2007 Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study Br J Dermatol 156 191 192 10.1111/j.1365-2133.2006. 07595.x
31. R von Pelchrzim T Schmook M Friedrich M Worm 2006 Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus Int J Dermatol 45 84 85 10.1111/j.1365-4632.2004.02539.x
32. SL Walker B Kirby RJ Chalmers 2002 The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus Br J Dermatol 147 405 406 10.1046/j.1365-2133.2002.488616.x
33. Wollenberg A, Reitamo S, Atzori F, Lahfa M, Ruzicka T, Healy E and others for the European Tacrolimus Ointment Study Group (2008) Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 63:742-750. doi: 10.1111/j.1398-9995.2008.01683.x
34. U Wollina G Hansel 2008 The use of topical calcineurin inhibitors in lupus erythematosus: an overview J Eur Acad Dermatol Venereol 22 1 6
35. DK Woo WD James 2005 Topical tacrolimus: a review of its uses in dermatology Dermatitis 16 6 21 10.2310/6620.2005.04045
36. E Wooltorton 2005 Eczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concerns CMAJ 172 1179 1180 10.1503/cmaj.050373
37. T Yoshimasu T Ohtani T Sakamoto A Oshima F Furukawa 2002 Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis Eur J Dermatol 12 50 52
38. E Zabawski 2002 Treatment of cutaneous lupus with Elidel Dermatol Online J 8 25